Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immucell (ICCC) Other Non Operating Income (2018 - 2024)

Immucell's Other Non Operating Income history spans 6 years, with the latest figure at -$143679.0 for Q2 2024.

  • For Q2 2024, Other Non Operating Income fell 94.97% year-over-year to -$143679.0; the TTM value through Jun 2024 reached -$170865.0, up 13.79%, while the annual FY2023 figure was -$21893.0, 88.3% up from the prior year.
  • Other Non Operating Income reached -$143679.0 in Q2 2024 per ICCC's latest filing, down from -$136476.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $827690.0 in Q4 2020 to a low of -$333776.0 in Q1 2020.
  • Average Other Non Operating Income over 5 years is -$25980.6, with a median of -$70723.0 recorded in 2020.
  • The largest YoY upside for Other Non Operating Income was 809.67% in 2023 against a maximum downside of 314.04% in 2023.
  • A 5-year view of Other Non Operating Income shows it stood at $827690.0 in 2020, then plummeted by 108.48% to -$70156.0 in 2021, then surged by 53.53% to -$32602.0 in 2022, then plummeted by 314.04% to -$134985.0 in 2023, then fell by 6.44% to -$143679.0 in 2024.
  • Per Business Quant, the three most recent readings for ICCC's Other Non Operating Income are -$143679.0 (Q2 2024), -$136476.0 (Q1 2024), and -$134985.0 (Q4 2023).